Order Article Reprints

Guo W, Liang D, Wang P, Yin L, Zhang H, Xing C, Huang Z, Wu Y, Li H, Cheng Z, et al. HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia. Pharmaceuticals. 2022; 15(6):734. https://doi.org/10.3390/ph15060734

Guo, Wancheng, Daomiao Liang, Peilong Wang, Le Yin, Huifang Zhang, Cheng Xing, Zineng Huang, Yinghua Wu, Heng Li, Zhao Cheng, and et al. 2022. "HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia" Pharmaceuticals 15, no. 6: 734. https://doi.org/10.3390/ph15060734

Guo, W., Liang, D., Wang, P., Yin, L., Zhang, H., Xing, C., Huang, Z., Wu, Y., Li, H., Cheng, Z., Xiao, X., Liu, J., Wang, Z., & Peng, H. (2022). HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia. Pharmaceuticals, 15(6), 734. https://doi.org/10.3390/ph15060734